{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:23:53Z","timestamp":1779110633841,"version":"3.51.4"},"reference-count":14,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,2,28]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Catastrophic antiphospholipid syndrome (CAPS) is a rare but severe form of antiphospholipid syndrome (APS). The syndrome manifests itself as a rapidly progressive multiorgan failure that is believed to be caused by widespread micro-thrombosis. Seldom does bleeding comanifest with thrombosis. We present a patient with APS who presented with nausea, vomiting and fatigue, and rapidly progressed into multiorgan failure before being diagnosed with CAPS. The clinical course was complicated by an atraumatic intracranial haemorrhage which demanded discontinuation of anticoagulation. The patient was treated with high dose steroid, intravenous immunoglobulin, followed by weekly rituximab infusion. Although the trigger for CAPS was not obvious during her hospital stay, she was diagnosed with acute cytomegalovirus (CMV) infection soon after discharge. In this case report, we explore the differential diagnoses of CAPS, investigate the possibility of CMV infection as a potential trigger, present the therapeutic challenges of anticoagulation and discuss the emerging use of rituximab.<\/jats:p>","DOI":"10.1136\/bcr-2018-227171","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T05:14:56Z","timestamp":1553145296000},"page":"e227171","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3115-7436","authenticated-orcid":false,"given":"Anju","family":"Adhikari","sequence":"first","affiliation":[{"name":"Internal Medicine, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2676-9577","authenticated-orcid":false,"given":"Mohammad Muhsin","family":"Chisti","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjog","family":"Bastola","sequence":"additional","affiliation":[{"name":"Internal Medicine, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ojbindra","family":"KC","sequence":"additional","affiliation":[{"name":"Internal Medicine, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"2025082703261822000_12.3.e227171.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22018"},{"key":"2025082703261822000_12.3.e227171.2","doi-asserted-by":"crossref","unstructured":"Asherson, R A . Multiorgan failure and antiphospholipid antibodies: The catastrophic antiphospholipid (Asherson\u2019s) syndrome (Vol. 210), 2005.","DOI":"10.1016\/j.imbio.2005.10.002"},{"key":"2025082703261822000_12.3.e227171.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.11.006"},{"key":"2025082703261822000_12.3.e227171.4","first-page":"1","article-title":"Transient Antiphospholipid Syndrome Associated with Primary Cytomegalovirus Infection: A Case Report and Literature Review","volume":"2014","author":"Nakayama","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"2025082703261822000_12.3.e227171.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200212337"},{"key":"2025082703261822000_12.3.e227171.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.5.388"},{"key":"2025082703261822000_12.3.e227171.7","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1361.088"},{"key":"2025082703261822000_12.3.e227171.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035241"},{"key":"2025082703261822000_12.3.e227171.9","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310395803"},{"key":"2025082703261822000_12.3.e227171.10","doi-asserted-by":"crossref","unstructured":"Uthman I , Noureldine MHA , Ruiz-Irastorza G , et al . Management of antiphospholipid syndrome. Ann Rheum Dis 2018. doi: 10.1136\/annrheumdis-2018-213846. [Epub ahead of print 3 Oct 2018].","DOI":"10.1136\/annrheumdis-2018-213846"},{"key":"2025082703261822000_12.3.e227171.11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410130073007"},{"key":"2025082703261822000_12.3.e227171.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0481-0"},{"key":"2025082703261822000_12.3.e227171.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.05.004"},{"key":"2025082703261822000_12.3.e227171.14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5152\/eurjrheum.2017.160073","article-title":"Catastrophic antiphospholipid syndrome treated with rituximab: a case report","volume":"4","author":"Do\u011fru","year":"2017","journal-title":"Eur J Rheumatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-227171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:26:24Z","timestamp":1756290384000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-227171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,20]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/bcr-2018-227171"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-227171","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}